-

Ken Frazier to Chair Transcarent Board of Directors

Former Merck Chairman and CEO and One of TIME’s 100 Most Influential People Joins Board, Committed to Meaningful Change in the Healthcare Industry for Consumers and Employers

PALO ALTO, Calif.--(BUSINESS WIRE)--Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care announced today that industry leader Ken Frazier has been appointed to chair the company’s board of directors. This addition to the Board is a formative milestone for Transcarent. As one of the most influential Chief Executive Officers in healthcare, Frazier brings unmatched experience and business acumen to help shape Transcarent’s long-term growth strategy.

Ken Frazier recently served as the Executive Chairman of the board of directors of Merck, where he was President and Chief Executive Officer for a decade, from 2011 to 2021. He is currently the chairman of General Catalyst’s Health Assurance Initiatives, focused on creating a more proactive, affordable, and equitable system of care.

“Ken’s experience in healthcare and business is unparalleled. He’s a seasoned executive and has been a member of some of the most prestigious industry boards including Merck and ExxonMobil,” said Glen Tullman, CEO of Transcarent. “Ken’s decision to join our Board further validates Transcarent’s mission to solve the industry’s most challenging issues, including making it easy for employees and their families to access high-quality, affordable health and care and ensuring the costs are manageable for employers who pay for care.”

Frazier is also a tireless advocate for social justice and economic inclusion. He co-founded and currently serves as co-chair of OneTen, a coalition of leading organizations committed to upskilling, hiring, and promoting one million Black Americans who lack four-year college degrees into family-sustaining jobs, of which Transcarent is a member. OneTen is committed to facilitating a meaningful, measurable, and lasting impact on our nation’s goal of equal opportunity.

“I’m not sure there is a problem more pressing than the accessibility and affordability of health and care to the average American worker,” said Ken Frazier. “Having run one of the largest companies in the country, I can tell you that the continued rapid escalation of healthcare costs will squeeze out other critical investments we need to make in this country, from infrastructure and innovation for businesses to education and national security for the U.S. government. I’m excited to join the Transcarent Board and to be part of an organization that is uniquely positioned to not only improve health and care delivery, but will do so in a way that makes it more equitable for the individual as well as their employer.”

About Transcarent

Transcarent is a health and care experience company that makes it easy for people to access high quality, affordable care. Through an integrated mobile or web platform, Members can access everyday care, for example, chat with a provider in less than 60 seconds, behavioral health, pharmacy care, care at home (or close to it), comprehensive surgical care, or receive additional care for complex care needs like cancer.

Transcarent takes accountability for results – offering at-risk pricing models and transparent impact reporting to align incentives towards measurably better experience, better health, and lower costs. For more Information, visit www.transcarent.com and follow on Twitter or LinkedIn.

Contacts

Media Contact:

For Transcarent
Leslie Krigstein
802-598-3305
Press@transcarent.com

Transcarent

Details
Headquarters: Denver, Colorado, USA
CEO: Glen Tullman
Employees: 2000
Organization: PRI

Release Versions

Contacts

Media Contact:

For Transcarent
Leslie Krigstein
802-598-3305
Press@transcarent.com

Social Media Profiles
More News From Transcarent

Transcarent Launches Innovative Bundled Payment Model for Breakthrough Cancer Therapies

SAN FRANCISCO--(BUSINESS WIRE)--Transcarent, the first agentic AI-powered health and care platform, today announced a first-of-its-kind bundled payment model for bispecific T-cell engager (BiTE) and CAR T therapies delivered through high-quality community providers, further enhancing their industry-leading complex care Centers of Excellence (COE) capabilities. The model enables Transcarent’s Cancer Care experience to bring advanced cancer care closer to where Members live while giving employers...

Transcarent Appoints Mike Morgan as Chief Commercial Officer to Accelerate Growth Across Employers, Health Plans, and Strategic Partners

SAN FRANCISCO--(BUSINESS WIRE)--Transcarent, the first agentic AI-powered health and care platform, today announced that Mike Morgan has joined the company as Chief Commercial Officer. Morgan will lead the company's commercial organization, overseeing sales, partnerships, and go-to-market strategy as Transcarent continues to expand adoption of its AI-powered WayFinding® platform among employers, health plans, and strategic partners. Morgan brings more than 20 years of commercial leadership expe...

Transcarent Appoints Anjali Jameson as Chief Product Officer

SAN FRANCISCO--(BUSINESS WIRE)--Transcarent, the first agentic AI-powered health and care platform, today announced that Anjali Jameson has joined the company as Chief Product Officer. Jameson will lead Transcarent’s product strategy and innovation efforts, with a focus on using the power of agentic AI, embedded in Transcarent’s WayFinding® platform, to proactively identify ways to dramatically improve the experience and quality of care for self-insured employers while breaking the cost curve,...
Back to Newsroom